At the protein level in Figure 2B, BRD9 was significantly upregulated in clear cell renal cell carcinoma (RCC) and LUAD, while it exhibited a significantly downregulated in uterine corpus endometrial carcinoma (UCEC). This evidence concerns the gene BRD9 and uterine corpus endometrial carcinoma.